-
SHR2415 is a highly potent, selective and orally active ERK1 and ERK2 inhibitor with IC50 values of 2.8 and 5.9 nM, respectively.
-
CP681301 is a potent CDK5 inhibitor, inhibits glioma stem cells self-renewal and shows anti-tumor activity.
-
ARD-69 is a potent PROTAC androgen receptor degrader and induces degradation of AR protein in AR-positive prostate cancer cell lines.
-
TK4g is a potent JAK inhibitor and can be used for studies of lymphatic-related diseases and leukemic cancers.
-
Simmiparib is a highly potent and orally active PARP1 and PARP2 inhibitor with IC50s of 1.75 nM and 0.22 nM, respectively. Antitumor effect.
-
G12Si-5, a potent, selective and reversible covalent inhibitor of the K-Ras G12S, can be used for the research of cancer.
-
EAI001 is a potent, selective mutant EGFR allosteric inhibitor. EAI001 has the potential for research on cancer.
-
LCS3 is a potent and reversible inhibitor of GSR and TXNRD1 with anti-tumour activity by non-competitive inhibition of the enzyme activity.
-
SPH5030 is a potent, selective, irreversible and orally active HER2 Inhibitor and shows anti-cancer activity.
-
BLU2864 is an orally active ATP-competitive PRKACA inhibitor. BLU2864 can be used in cancer and polycystic kidney disease research.
Categories
Diseases
Others
Archives
- March 2023 (14)
- February 2023 (18)
- January 2023 (14)
- December 2022 (21)
- November 2022 (14)
- October 2022 (16)
- September 2022 (13)
- August 2022 (13)
- July 2022 (12)
- June 2022 (12)
- May 2022 (13)
- April 2022 (10)
- March 2022 (9)
- February 2022 (8)
- January 2022 (14)
- December 2021 (13)
- November 2021 (13)
- October 2021 (13)
- September 2021 (11)
- August 2021 (17)
- July 2021 (19)
- June 2021 (18)
- May 2021 (18)
- April 2021 (17)
- March 2021 (19)
- February 2021 (16)
- January 2021 (20)
- December 2020 (16)
- November 2020 (16)
- October 2020 (17)
- September 2020 (18)
- August 2020 (17)
- July 2020 (18)
- June 2020 (17)
- May 2020 (17)
- April 2020 (18)
- March 2020 (17)
- February 2020 (14)
- January 2020 (16)
- December 2019 (19)
- November 2019 (15)
- October 2019 (17)
- September 2019 (28)
- August 2019 (31)
- July 2019 (31)
- June 2019 (32)
- May 2019 (31)
- April 2019 (32)
- March 2019 (7)